Xvivo Perfusion AB (XVIPF)
30.95
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Xvivo Perfusion Shareholders Equity (Quarterly) : 227.34M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 227.34M |
| March 31, 2026 | 227.73M |
| December 31, 2025 | 229.26M |
| September 30, 2025 | 222.62M |
| June 30, 2025 | 219.50M |
| March 31, 2025 | 208.30M |
| December 31, 2024 | 195.20M |
| September 30, 2024 | 205.51M |
| June 30, 2024 | 191.20M |
| March 31, 2024 | 187.34M |
| December 31, 2023 | 193.00M |
| September 30, 2023 | 177.47M |
| June 30, 2023 | 139.18M |
| March 31, 2023 | 139.53M |
| December 31, 2022 | 137.26M |
| September 30, 2022 | 124.50M |
| June 30, 2022 | 131.34M |
| March 31, 2022 | 139.45M |
| December 31, 2021 | 141.98M |
| September 30, 2021 | 115.74M |
| June 30, 2021 | 118.16M |
| March 31, 2021 | 117.24M |
| December 31, 2020 | 122.80M |
| September 30, 2020 | 116.41M |
| June 30, 2020 | 61.14M |
| Date | Value |
|---|---|
| March 31, 2020 | 59.48M |
| December 31, 2019 | 61.69M |
| September 30, 2019 | 59.26M |
| June 30, 2019 | 61.82M |
| March 31, 2019 | 58.50M |
| December 31, 2018 | 60.96M |
| September 30, 2018 | 60.12M |
| June 30, 2018 | 59.84M |
| March 31, 2018 | 60.68M |
| December 31, 2017 | 61.60M |
| September 30, 2017 | 61.10M |
| June 30, 2017 | 59.42M |
| March 31, 2017 | 35.36M |
| December 31, 2016 | 34.83M |
| September 30, 2016 | 36.70M |
| June 30, 2016 | 36.95M |
| March 31, 2016 | 22.82M |
| December 31, 2015 | 21.93M |
| September 30, 2015 | 21.36M |
| June 30, 2015 | 21.40M |
| March 31, 2015 | 20.84M |
| December 31, 2014 | 22.51M |
| September 30, 2014 | 24.02M |
| June 30, 2014 | 25.39M |
| March 31, 2014 | 15.17M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Getinge AB | 3.197B |
| Paxman AB | 43.08M |
| Enovis Corp. | 1.477B |
| Edwards Lifesciences Corp. | 10.62B |
| Intuitive Surgical, Inc. | 18.17B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 261.09M |
| Total Liabilities (Quarterly) | 33.75M |
| Debt to Equity Ratio | 0.0553 |
| Current Ratio | 3.860 |
| Net Debt Paydown Yield | -0.21% |